Anti-MIF Antibody (1P815)

Name: Anti-MIF Antibody (1P815)
Brand: TargetMol
SKU: TMAH-00757
Rating: 4.5 (1 reviews)

还可以

产品编号 TMAH-00757

别名 MMIF, macrophage migration inhibitory factor (glycosylation-inhibiting factor), GLIF, GIF

Anti-MIF Antibody (1P815) 是一种抗体，靶向 MIF。Anti-MIF Antibody (1P815) 可用于 ELISA, WB。

Anti-MIF Antibody (1P815)

还可以

产品编号 TMAH-00757 别名 MMIF, macrophage migration inhibitory factor (glycosylation-inhibiting factor), GLIF, GIF

Anti-MIF Antibody (1P815) 是一种抗体，靶向 MIF。Anti-MIF Antibody (1P815) 可用于 ELISA, WB。

规格	价格	库存	数量
50 μL	¥ 1,300	5日内发货
100 μL	¥ 2,195	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

联系我们获取更多批次信息

资源下载

产品介绍

生物活性

产品描述	Anti-MIF Antibody (1P815) is an antibody targeting MIF. Anti-MIF Antibody (1P815) can be used in ELISA, WB.
别名	MMIF, macrophage migration inhibitory factor (glycosylation-inhibiting factor), GLIF, GIF
Ig Type	Rabbit IgG
克隆号	1P815
交叉反应	Human
验证活性	Western Blot -Positive WB detected in: HL60 whole cell lysate, 293 whole cell lysate, PC-3 whole cell lysate, K562 whole cell lysate -All lanes: MIF antibody at 1:1500 -Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution -Predicted band size: 13 kDa -Observed band size: 13 kDa
应用	ELISA WB
推荐剂量	WB:1:500-1:5000.
抗体种类	Monoclonal
亚细胞定位	Secreted. Cytoplasm.
构建方式	Recombinant Antibody
纯化方式	Affinity-chromatography
性状	Liquid
缓冲液	Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
研究背景	Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.